CDK8 and breast carcinoma: Here, we have demonstrated that pharmacological inhibition of CDK8 in colon cancer cell lines HCT116 and Colo205 resulted in depletion of β–catenin protein while the same treatment of breast cancer cell line MDA-MB-468 did not appear to change β–catenin content (Supplemental Figure S1).